Matton Orthomedi acquired by Ottobock
Context
In May 2025, Ottobock, through its subsidiary Vigo, acquired Matton OrthoMedi as part of its strategy to consolidate the European technical orthopedics market. The primary objective of this acquisition is to strengthen Ottobock's network of care centers in Western Europe by integrating a well-established local player in Belgium. Matton OrthoMedi brings a established network of locations in Ghent, Bruges, and Brussels, as well as over 30 years of expertise in orthopedic care and custom device manufacturing, catering to patients with complex mobility needs. As part of this integration, Matton OrthoMedi will retain its operational identity and continue to operate autonomously, while leveraging Ottobock's industrial, clinical, and organizational resources. The goal is to optimize patient care pathways by enhancing coordination between local facilities and the group's treatment standards. Strategically, this acquisition enables Ottobock to accelerate its presence in the consolidating European orthopedics market, where value is shifting towards integrated networks that can combine patient proximity, practice standardization, and skill sharing. This deal is part of a platform strategy, aiming to aggregate specialized local players to build a more integrated, efficient, and patient-centric European orthopedic care network. By expanding its footprint in the region, Ottobock is poised to capitalize on the trend towards integrated care delivery, where providers can offer comprehensive and coordinated services to patients, ultimately driving better outcomes and improved patient satisfaction.
Matton Orthomedi, which reported an EBITDA margin of [members only] in 2025, is valued in this transaction at an EV/EBITDA multiple of [members only].
-> Deep-dive in Healthcare & Pharma market trends
Target
Matton OrthoMedi is a leading Belgian player in the field of technical orthopedics and mobility solutions for patients. The company offers a comprehensive range of medical devices, including prosthetics, orthotics, orthopedic shoes, custom insoles, wheelchairs, and other mobility aids. With over 30 years of experience, Matton OrthoMedi has established itself as a trusted healthcare provider in Belgium, known for its patient-centric approach and extensive network of centers in Ghent, Bruges, and Brussels. The company employs approximately 68 specialized professionals who are dedicated to providing orthopedic care and functional rehabilitation. Its business model is built on strong technical expertise and the ability to deliver tailored solutions to complex medical needs, particularly in cases of reduced mobility. As a well-established player in the Belgian technical orthopedics market, Matton OrthoMedi enjoys significant local recognition. Following its integration into the Vigo network and subsequently the Ottobock group, the company has become part of a broader European platform, while maintaining its local roots and close relationships with patients.
Ent. Value
€10–30M
Equity Value
[members only]
Multiples
EV / Revenue
2x–6x
EV / EBITDA
[members only]
EV / EBIT
[members only]
Historical Financials (EUR)
Other operations with Ottobock
Similar deals in Life Sciences
| Date | Acquirer | Target | Country | Sector |
|---|---|---|---|---|
| 07/2025 | PATRICIA INDUSTRIES | NOVA BIOMEDICAL | UNITED STATES | Diagnostic Equipment |
| 07/2025 | BC PARTNERS | BIOGARAN | FRANCE | Pharma & Biotech |
| 05/2025 | IK PARTNERS | BIOBANK | FRANCE | Implants & Prosthetics |
| 04/2025 | INSTITUT MERIEUX / ARCHIMED | CEVA SANTE ANIMALE | FRANCE | Animal Health |
| 04/2025 | IK PARTNERS | STERIMED | FRANCE | Medical Consumables |
| 04/2025 | NORGINE | THERAVIA | FRANCE | Generics / Labs |
| 04/2025 | CINVEN | NUTRISENS | FRANCE | Nutrition & Dietary Supplements |
| 04/2025 | PATIENT SQUARE CAPITAL | PATTERSON COMPANIES | UNITED STATES | Medical Consumables |
| 04/2025 | KNOP INVESTMENTS | AVANCE CARE GROUP | NETHERLANDS | Medical Devices |
| 03/2025 | NUTRISENS | PRODIET | BRAZIL | Nutrition & Dietary Supplements |
REFERENCES
Valuation range: EV €10–30M
Revenue range: €5–25M
EV/Revenue range: 2x - 6x
Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of Matton Orthomedi by Ottobock are reserved for mynth community members. Register for free to unlock full data.
Authors: This transaction was contributed by a verified mynth contributor and cross-checked against available transaction documents and official company communications.
Target: matton orthomedi
FAQ
What transaction does this page cover?
How was the acquisition of Matton Orthomedi by Ottobock valued, and what multiples were paid?
What was Matton Orthomedi’s revenue at the time of the deal?
What sources support the information on this transaction?
What is mynth?